Level VI lymph node dissection for papillary thyroid cancer

Minerva Chirurgica

Volumn 62, Issue 5, 2007, Pages 383-393

  White, M L ^a,b   Doherty, G M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b ST JOSEPH MERCY HOSPITAL   (United States)

Author keywords

Lymph node excision Carcinoma; Papillary Thyroid neoplasms; Surgery

Indexed keywords

EVIDENCE BASED MEDICINE; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; METHODOLOGY; NECK DISSECTION; PAPILLARY CARCINOMA; PATHOLOGY; REVIEW; THYROID TUMOR; THYROIDECTOMY; TREATMENT OUTCOME;

CARCINOMA, PAPILLARY; EVIDENCE-BASED MEDICINE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NECK DISSECTION; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 36649012780     PISSN: 00264733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Wong CK, Wheeler MH. Thyroid nodules: rational management. World J Surg 2000;24:934-41.
2. Sherman SI. Thyroid carcinoma. Lancet 2003;361:501-11.
3. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006;16:109-42.
4. Caron NR, Clark OH. Papillary thyroid cancer: surgical management of lymph node metastases. Curr Treat Options Oncol 2005;6:311-22.
5. Hamming JF, Roukema JA. Management of regional lymph nodes in papillary, follicular, and medullary thyroid cancer. In: Clark OH, Duh Q-Y, Kebebew E, editors. Textbook of endocrine surgery, 2nd ed. Philadelphia: W.B. Saunders 2005. p.195-206.
6. Tisell LE, Hansson G, Jansson S, Salander H. Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery 1986;99: 60-6.
7. Grodski S, Cornford L, Sywak M, Sidhu S, Delbridge L. Routine level VI lymph node dissection for papillary thyroid cancer: surgical technique. ANZ J Surg 2007;77: 203-8.
8. Gauger PG. Thyroid Gland. In: Mulholland MW, Lillemoe KD, Doherty GM, editors. Greenfield's surgery: scientific principles and practice, 4th ed. Philadelphia: Lippincott Williams & Wilkins 2006.p. 1289-309.
9. Machens A, Hinze R, Thomusch O, Dralle H. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 2002;26:22-8.
10. Qubain SW, Nakano S, Baba M, Takao S, Aikou T. Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery 2002;131: 249-56.
11. Gimm O, Rath FW, Dralle H. Pattern of lymph node metastases in papillary thyroid carcinoma. Br J Surg 1998;85:252-4.
12. Machens A, Holzhausen HJ, Dralle H. Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg 2004;139:43-5.
13. Robbins KT, Medina JE, Wolfe GT, Levine PA, Sessions RB, Pruet CW. Standardizing neck dissection terminology. Official report of the Academy's Committee for Head and Neck Surgery and Oncology. Arch Otolaryngol Head Neck Surg 1991;117:601-5.
14. Robbins KT, Clayman G, Levine PA, Medina J, Sessions R, Shaha A et al. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 2002;128:751-8.
15. White ML, Gauger PG, Doherty GM. Central lymph node dissection in differentiated thyroid cancer. "World J Surg 2007;31:895-904.
16. Scheumann GF, Gimm O, Wegener G, Hundeshagen H, Dralle H. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 1994;18:559-67.
17. Henry JF, Gramatica L, Denizot A, Kvachenyuk A, Puccini M, Defechereux T. Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma. Langenbecks Arch Surg 1998;383:167-9.
18. Pereira JA, Jimeno J, Miquel J, Iglesias M, Munne A, Sancho JJ et al. Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery 2005;138:1095-101.
19. Shindo M, Wu JC, Park EE, Tanzella F. The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer. Arch Otolaryngol Head Neck Surg 2006;132:650-4.
20. Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 2003;237:399-407.
21. Rossi RL, Cady B, Silverman ML, Wool MS, and Horner TA. Current results of conservative surgery for differentiated thyroid carcinoma. World J Surg 1986;10:612-22.
22. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-28.
23. Hughes CJ, Shaha AR, Shah JP, Loree TR. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck 1996;18:127-32.
24. Cady B, Sedgwick CE, Meissner WA, Wool MS, Salzman FA, Werber J. Risk factor analysis in differentiated thyroid cancer. Cancer 1979;43:810-20.
25. Hay ID, Grant CS, Taylor WF, McConahey WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987;102:1088-95.
26. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114:1050-8.
27. Lundgren CI, Hall P, Dickman PW, Zedenius J. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 2006;106:524-31.
28. Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 2004;135:139-48.
29. Vassilopoulou-Sellin R, Schultz PN, Haynie TP. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy. Cancer 1996;78:493-501.
30. Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1989;95:2S-4S.
31. Heinrich S, Schafer M, Rousson V, Clavien PA. Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg 2006;243:154-68.
32. Udelsman R, Lakatos E, Ladenson P. Optimal surgery for papillary thyroid carcinoma. World J Surg 1996;20:88-93.
33. Tisell LE, Nilsson B, Molne J, Hansson G, Fjalling M, Jansson S et al. Improved survival of patients with papillary thyroid cancer after surgical microdissection. World J Surg 1996;20:854-9.
34. Shah MD, Hall FT, Eski SJ, Witterick IJ, Walfish PG, Freeman JL. Clinical course of thyroid carcinoma after neck dissection. Laryngoscope 2003;113:2102-7.
35. Steinmuller T, Klupp J, Rayes N, Ulrich F Jonas S, Graf KJ et al. Prognostic factors in patients with differentiated thyroid carcinoma. Eur J Surg 2000;166:29-33
36. Noguchi S, Murakami N, Yamashita H, Toda M, Kawamoto H. Papillary thyroid carcinoma: modified radical neck dissection improves prognosis. Arch Surg 1998;133:276-80.
37. Sywak M, Cornford L, Roach P, Stalberg P, Sidhu S, Delbridge L. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 2006;140:1000-7.
38. Simon D, Goretzki PE, Witte J, Roher HD. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg 1996;20:860-6.
39. Leboulleux S, Rubino C, Baudin E, Caillou B, Hartl DM, Bidart JM et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 2005;90:5723-9.
40. Baudin E, Travagli JP, Ropers J, Mancusi F, Bruno-Bossio G, Caillou B et al. Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer 1998;83:553-9.
41. Sato N, Oyamatsu M, Koyama Y, Emura I, Tamiya Y, Hatakeyama K. Do the level of nodal disease according to the TNM classification and the number of involved cervical nodes reflect prognosis in patients with differentiated carcinoma of the thyroid gland? J Surg Oncol 1998;69:151-5.
42. Ito Y, Jikuzono T, Higashiyama T, Asahi S, Tomoda C, Takamura Y et al. Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J Surg 2006;30:1821-8.
43. Clark OH, Levin K, Zeng QH, Greenspan FS, Siperstein A. Thyroid cancer: the case for total thyroidectomy. Eur J Cancer Clin Oncol 1988;24:305-13.
44. Ley PB, Roberts JW, Symmonds RE, Hendricks JC, Snyder SK, Frazee RC et al. Safety and efficacy of total thyroidectomy for differentiated thyroid carcinoma: a 20-year review. Am Surg 1993;59:110-4.
45. Rosato L, Avenia N, Bernante P, De Palma M, Gulino G, Nasi PG et al. Complications of thyroid surgery: analysis of a multicentric study on 14 934 patients operated on in Italy over 5 years. World J Surg 2004;28:271-6.
46. Gemsenjager E, Perren A, Seifert B, Schuler G, Schweizer I, Heitz PU. Lymph node surgery in papillary thyroid carcinoma. J Am Coll Surg 2003;197:182-90.
47. Steinmuller T, Klupp J, Wenking S, Neuhaus P. Complications associated with different surgical approaches to differentiated thyroid carcinoma. Langenbecks Arch Surg 1999;384:50-3.
48. Goropoulos A, Karamoshos K, Christodoulou A, Ntitsias T, Paulou K, Samaras A et al. Value of the cervical compartments in the surgical treatment of papillary thyroid carcinoma. World J Surg 2004;28:1275-81.
49. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K et al. Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg 2006;30:91-9.
50. Segal K, Friedental R, Lubin E, Shvero J, Sulkes J, Feinmesser R. Papillary carcinoma of the thyroid. Otolaryngol Head Neck Surg 1995;113:356-63.
51. Moley JF, Lairmore TC, Doherty GM, Brunt LM, DeBenedetti MK. Preservation of the recurrent laryngeal nerves in thyroid and parathyroid reoperations. Surgery 1999;126:673-9.
52. Kim MK, Mandel SH, Baloch Z, Livolsi VA, Langer JE, Didonato L et al. Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg 2004;130: 1214-6.
53. Uruno T, Miyauchi A, Shimizu K, Nakano K, Takamura Y, Ito Y et al. Prognosis after reoperation for local recurrence of papillary thyroid carcinoma. Surg Today 2004;34:891-5.
54. Kouvaraki MA, Lee JE, Shapiro SE, Sherman SI, Evans DB. Preventable reoperations for persistent and recurrent papillary thyroid carcinoma. Surgery 2004;136: 1183-91.